These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Exempt Terminated 2008-000364-16 Ensayo clínico abierto de fase I para evaluar la eficacia y seguridad del tratamiento con células mesenquimales autólogas infectadas con un nuevo adenovirus oncolítico en el tratamiento de pacientes p... not-yet-due
Exempt 2008-008688-80 Ensayo clínico en fase I para evaluar el tratamiento de tumores infantiles del sistema nervioso central refractarios o recurrentes con ICOVIR5 not-yet-due
Ongoing 2009-010186-23 TRASPLANTE HAPLOIDÉNTICO E INFUSIÓN DE CÉLULAS NK ESTIMULADAS CON IL-15 EN PACIENTES CON TUMORES SÓLIDOS REFRACTARIOS not-yet-due
Exempt 2011-006100-12 Clinical Trial Phase I / II to evaluate the safety and efficacy of the infusion of autologous CD34+ cells transduced with a lentiviral vector carrying the FANCA gene (orphan drug) for patients with Fa... not-yet-due
Ongoing 2019-001154-26 Feasibility clinical trial of the combination of AloCelyvir with chemotherapy and radiotherapy for the treatment of children and adolescents with relapsed or refractory extracranial solid tumors. E... not-yet-due
Completed, but no date, and reported results Terminated 2020-001450-22 Phase II Clinical Trial to explore the efficacy of allogeneic mesenchymal cells from umbilical cord tissue in patients with severe pulmonary involvement by COVID-19. Ensayo Clínico Fase II para exp... bad-data
Exempt 2020-004838-37 Phase IB clinical trial to assess the safety, tolerability, and preliminary efficacy of AloCELYVIR (Mesenchymal allogenic cells + ICOVIR-5) in children, adolescent and young adults with newly diagnose... not-yet-due